Prediction model for prolonged fever in patients with Mycoplasma pneumoniae pneumonia: a retrospective study of 716 pediatric patients

被引:15
|
作者
Jang, Min Sik [1 ]
Kim, Bit Gyeol [1 ]
Kim, Jihye [1 ]
机构
[1] Hallym Univ, Coll Med, Dept Pediat, Kangdong Sacred Heart Hosp, 150 Seongan Ro, Seoul 05355, South Korea
关键词
Mycoplasma pneumoniae pneumonia; Refractory; Prediction model; MACROLIDE RESISTANCE; CYTOKINES; THERAPY; SURVEILLANCE; INFECTION;
D O I
10.1186/s12890-021-01534-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective To identify patients with Mycoplasma pneumoniae pneumonia (MPP) with a risk of prolonged fever while on macrolides. Methods A retrospective study was performed with 716 children admitted for MPP. Refractory MPP (RMPP-3) was defined as fever persisting for > 72 h without improvement in clinical and radiologic findings after macrolide antibiotics (RMPP-3) or when fever persisted for > 120 h (RMPP-5) without improvement in clinical and radiologic findings. Radiological data, laboratory data, and fever profiles were compared between the RMPP and non-RMPP groups. Fever profiles included the highest temperature, lowest temperature, and frequency of fever. Prediction models for RMPP were created using the logistic regression method and deep neural network. Their predictive values were compared using receiver operating characteristic curves. Results Overall, 716 patients were randomly divided into two groups: training and test cohorts for both RMPP-3 and RMPP-5. For the prediction of RMPP-3, a conventional logistic model with radiologic grouping showed increased sensitivity (63.3%) than the model using laboratory values. Adding laboratory values in the prediction model using radiologic grouping did not contribute to a meaningful increase in sensitivity (64.6%). For the prediction of RMPP-5, laboratory values or radiologic grouping showed lower sensitivities ranging from 12.9 to 16.1%. However, prediction models using predefined fever profiles showed significantly increased sensitivity for predicting RMPP-5, and neural network models using 12 sequential fever data showed a greatly increased sensitivity (64.5%). Conclusion RMPP-5 could not be effectively predicted using initial laboratory and radiologic data, which were previously reported to be predictive. Further studies using advanced mathematical models, based on large-sized easily accessible clinical data, are anticipated for predicting RMPP.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Significant changes in the levels of myocardial enzyme in the child patients with Mycoplasma pneumoniae pneumonia
    Qi, Xueliang
    Sun, Xiangguo
    Li, Xuemin
    Kong, Dejin
    Zhao, Luhua
    CELLULAR AND MOLECULAR BIOLOGY, 2020, 66 (06) : 41 - 45
  • [32] Plasma soluble B7-H3 levels for severity evaluation in pediatric patients with Mycoplasma pneumoniae pneumonia
    Xu, Yunyun
    Yu, Lexiang
    Hao, Chuangli
    Wang, Yuqing
    Zhu, Canhong
    Ji, Wei
    Li, Yiping
    Li, Gang
    Chen, Zhengrong
    Yan, Yongdong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 73 : 163 - 171
  • [33] Assessment of levels of D-dimer and interferon- in pediatric patients with Mycoplasma pneumoniae pneumonia and its clinical implication
    Jin, Xiaoqiu
    Zhu, Ying
    Zhang, Yingchun
    Chen, Jing
    Rong, Li
    Zhao, Xuesong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 5025 - 5030
  • [34] Implementation of Point-of-Care Molecular Diagnostics for Mycoplasma pneumoniae Ensures the Correct Antimicrobial Prescription for Pediatric Pneumonia Patients
    Hayashi, Daisuke
    Akashi, Yusaku
    Suzuki, Hiromichi
    Shiigai, Masanari
    Kanemoto, Koji
    Notake, Shigeyuki
    Ishiodori, Takumi
    Ishikawa, Hiroichi
    Imai, Hironori
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 246 (04): : 225 - 231
  • [35] Intestinal bacteria flora changes in patients with Mycoplasma pneumoniae pneumonia with or without wheezing
    Jiang, Yonghong
    Bao, Chunxiu
    Zhao, Xiaoyang
    Chen, Yiliu
    Song, Yao
    Xiao, Zhen
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients
    He, Mengyuan
    Xie, Junfeng
    Rui, Pu
    Li, Xiaoyu
    Lai, Min
    Xue, Hongman
    Chen, Chun
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [37] Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients
    Ishiguro, Nobuhisa
    Koseki, Naoko
    Kaiho, Miki
    Ariga, Tadashi
    Kikuta, Hideaki
    Togashi, Takehiro
    Oba, Koji
    Morita, Keisuke
    Nagano, Naoko
    Nakanishi, Masanori
    Hara, Kazuya
    Hazama, Kyosuke
    Watanabe, Toru
    Yamanaka, Tatsuru
    Sasaki, Satoshi
    Furuyama, Hideto
    Shibata, Mutsuo
    Shida, Satoru
    Ishizaka, Akihito
    Tabata, Yuichi
    Aoyagi, Hayato
    Naito, Hiroyuki
    Yoshioka, Mikio
    Horino, Atsuko
    Kenri, Tsuyoshi
    PLOS ONE, 2017, 12 (03):
  • [38] A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia
    Shaoxiu Song
    Yongsheng Xu
    BMC Pediatrics, 23
  • [39] A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia
    Song, Shaoxiu
    Xu, Yongsheng
    BMC PEDIATRICS, 2023, 23 (01)
  • [40] Clinical profiles of Mycoplasma pneumoniae pneumonia in children with different pleural effusion patterns: a retrospective study
    Li, Shuxian
    Zhou, Junfen
    He, Jing
    Yang, Dehua
    Zhu, Guohong
    Tang, Lanfang
    Chen, Zhimin
    BMC INFECTIOUS DISEASES, 2024, 24 (01)